Table 1.

Patient characteristics of breast cancer primary, liver metastasis and details of prior systemic therapy.

Patient	Age	Treatment of Primary Ca	Axillary LN Status	Receptor Status	Extrahepatic metastasis before TACE	Interval between Diagnosis of Primary Breast Cancer and Liver Metastasis (in months)	Liver Metastasis Extent	Largest Liver Metastasis Size (in cm)	Previous Systemic Chemotherapy	Hormonal Treatment	Trastuzumab
1	35	mastectomy	positive	ER − PR − HER2/neu +	L4 bone	0	multiple bilobar	5.5 × 2.7	yes	no	yes
2	44	mastectomy	positive	ER + PR + HER2/neu +	T12 bone	95	multiple bilobar	12.2 × 5.2	yes	yes	yes
3	52	lumpectomy radiation, axillary LND	positive	ER − PR − HER2/neu −	None	14	multiple bilobar	13.4 × 8.2	yes	no	no
4	34	mastectomy	positive	ER + PR − HER2/neu −	None	24	multiple bilobar	6.9 × 5.2	yes	yes	no
5	40	lumpectomy radiation, axillary LND	positive	ER + PR +	multiple vertebral bones	60	multiple bilobar	10.0 × 9.0	yes	yes	no
6	60	mastectomy	positive	ER + PR +	None	0	multiple bilobar	13.0 × 8.6	yes	yes	no
7	51	axillary LND	positive	ER − PR − HER2/neu +	None	0	multiple bilobar	6.2 × 4.8	yes	no	yes
8	29	lumpectomy radiation	positive	ER − PR − HER2/neu +	None	16	multiple bilobar	4.9 × 4.1	yes	no	yes
9	49	lumpectomy radiation, axillary LND	positive	ER + PR + HER2/neu −	multiple vertebral bones, Calcaneus	93	multiple bilobar	2.9 × 2.1	yes	yes	no
10	54	mastectomy	positive	ER + PR − HER2/neu −	C3, C4, C5 vertebral bones	80	right lobe	11.0 × 8.0	yes	yes	no